SRR
Serine racemase
Also known as: ILV1, ISO1, SRR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9GZT4
- Gene
- SRR
- Ensembl
- ENSG00000167720
- Chromosome
- 17
- Canonical length
- 340 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables several functions, including L-serine ammonia-lyase activity; PDZ domain binding activity; and heterocyclic compound binding activity. Involved in carboxylic acid metabolic process and response to lipopolysaccharide. Located in cytoplasm and neuronal cell body. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
340 residues, UniProt reviewed canonical sequence.
>Q9GZT4|SRR
1 MCAQYCISFA DVEKAHINIR DSIHLTPVLT SSILNQLTGR NLFFKCELFQ KTGSFKIRGA
61 LNAVRSLVPD ALERKPKAVV THSSGNHGQA LTYAAKLEGI PAYIVVPQTA PDCKKLAIQA
121 YGASIVYCEP SDESRENVAK RVTEETEGIM VHPNQEPAVI AGQGTIALEV LNQVPLVDAL
181 VVPVGGGGML AGIAITVKAL KPSVKVYAAE PSNADDCYQS KLKGKLMPNL YPPETIADGV
241 KSSIGLNTWP IIRDLVDDIF TVTEDEIKCA TQLVWERMKL LIEPTAGVGV AAVLSQHFQT
301 VSPEVKNICI VLSGGNVDLT SSITWVKQAE RPASYQSVSVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SRR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- retina: 15 nTPM
- skeletal muscle: 15 nTPM
- bone marrow: 13 nTPM
- cerebral cortex: 13 nTPM
- parathyroid gland: 12 nTPM
- pancreas: 11 nTPM
Single-cell type
- epicardial cells: 162 nCPM
- cardiomyocytes: 103 nCPM
- early primary spermatocytes: 44 nCPM
- adipocytes: 26 nCPM
- endometrial secretory cells: 24 nCPM
- adrenal medulla cells: 21 nCPM
Immune cell
- myeloid DC: 16 nTPM
- NK-cell: 16 nTPM
- non-classical monocyte: 14 nTPM
- naive CD8 T-cell: 12 nTPM
- memory CD4 T-cell: 11 nTPM
- plasmacytoid DC: 11 nTPM
Brain region
- hypothalamus: 42 nTPM
- choroid plexus: 40 nTPM
- thalamus: 40 nTPM
- midbrain: 40 nTPM
- medulla oblongata: 40 nTPM
- cerebellum: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- D-serine metabolic process
- L-serine metabolic process
- pyruvate biosynthetic process
- response to ketamine
- response to lipopolysaccharide
- response to xenobiotic stimulus
- D-serine biosynthetic process
- serine family amino acid metabolic process
Molecular functions
- ATP binding
- calcium ion binding
- glycine binding
- identical protein binding
- L-serine ammonia-lyase activity
- magnesium ion binding
- PDZ domain binding
- protein homodimerization activity
- pyridoxal phosphate binding
- D-serine ammonia-lyase activity
- serine racemase activity
- threonine racemase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SRR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SRR as an antibody target. Whether an autoantibody or antibody against SRR could matter depends on whether native SRR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SRR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SRR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...